267 related articles for article (PubMed ID: 19908069)
1. Membranous nephropathy in children: clinical presentation and therapeutic approach.
Menon S; Valentini RP
Pediatr Nephrol; 2010 Aug; 25(8):1419-28. PubMed ID: 19908069
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
4. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
Ponticelli C; Altieri P; Scolari F; Passerini P; Roccatello D; Cesana B; Melis P; Valzorio B; Sasdelli M; Pasquali S; Pozzi C; Piccoli G; Lupo A; Segagni S; Antonucci F; Dugo M; Minari M; Scalia A; Pedrini L; Pisano G; Grassi C; Farina M; Bellazzi R
J Am Soc Nephrol; 1998 Mar; 9(3):444-50. PubMed ID: 9513907
[TBL] [Abstract][Full Text] [Related]
5. PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.
Hoxha E; Harendza S; Pinnschmidt H; Panzer U; Stahl RA
PLoS One; 2014; 9(10):e110681. PubMed ID: 25313791
[TBL] [Abstract][Full Text] [Related]
6. Nonimmunosuppressive therapy of membranous nephropathy.
Schieppati A; Ruggenenti P; Perna A; Remuzzi G
Semin Nephrol; 2003 Jul; 23(4):333-9. PubMed ID: 12923721
[TBL] [Abstract][Full Text] [Related]
7. Treatment of membranous nephropathy in children.
Makker SP
Semin Nephrol; 2003 Jul; 23(4):379-85. PubMed ID: 12923726
[TBL] [Abstract][Full Text] [Related]
8. [Membranous glomerulonephritis].
Scheidat S; Stahl RA
Internist (Berl); 2003 Sep; 44(9):1120-30. PubMed ID: 14566465
[TBL] [Abstract][Full Text] [Related]
9. Membranous glomerulonephritis: treatment response and outcome in children.
Valentini RP; Mattoo TK; Kapur G; Imam A
Pediatr Nephrol; 2009 Feb; 24(2):301-8. PubMed ID: 18846392
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
[TBL] [Abstract][Full Text] [Related]
12. [Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
Muñoz Díaz AB; Aguilar P
Nefrologia; 2004; 24 Suppl 3():76-80. PubMed ID: 15219075
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic membranous nephropathy: diagnosis and treatment.
Fervenza FC; Sethi S; Specks U
Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids, cyclophosphamide, and chlorambucil therapy of membranous nephropathy.
Passerini P; Ponticelli C
Semin Nephrol; 2003 Jul; 23(4):355-61. PubMed ID: 12923723
[TBL] [Abstract][Full Text] [Related]
15. Treatment of the nephrotic syndrome with cyclosporin A.
Ponticelli C
J Autoimmun; 1992 Apr; 5 Suppl A():315-24. PubMed ID: 1503627
[TBL] [Abstract][Full Text] [Related]
16. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Liu ID; Willis NS; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.
Chen A; Frank R; Vento S; Crosby V; Chandra M; Gauthier B; Valderrama E; Trachtman H
BMC Nephrol; 2007 Aug; 8():11. PubMed ID: 17683621
[TBL] [Abstract][Full Text] [Related]
19. Optimal blood pressure control versus additional immunosuppressive therapy in idiopathic membranous nephropathy - a retrospective analysis.
Dikow R; Quentmeier P; Schwenger V; Waldherr R; Andrassy K; Ritz E; Zeier M
Clin Nephrol; 2009 Nov; 72(5):366-72. PubMed ID: 19863879
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]